Moreover, ADIPOQ is a potent inhibitor of the PI3K-mTOR pathway, either through phosphorylation of the protein raptor, a component of mTOR complex 1 (mTORC1), or by regulating the activity of tuberin (TSC2), which is a tumour suppressor. Here, ADIPOQ is linked to neoplasm.